Actin vs Zeuss
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Actin
Best for affordable compounded semaglutide with B12 enhancementStarting at $133/mo
Zeuss
Best for Buyers who actively dislike subscription auto-renewals and want a one-time-purchase model for compounded GLP-1 or GIP/GLP-1 — the only provider in the WLR directory offering this billing model. Strong fit for cost-conscious patients who want bundled transparency (provider review + meds + cold-chain shipping + delivery for $125-$175) and the option to order only when needed.Starting at $125/mo
Side-by-Side Comparison
| Feature | Actin | Zeuss |
|---|---|---|
| Overall Score | 7.0/10 | 7.0/10 |
| Starting Price | $133/mo | ✓$125/mo |
| Editorial Rating | 3.5 ★ /5 | 3.5 ★ /5 |
| Features | 2 features | ✓10 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Actin
Pros
- ✓Semaglutide + B12 combination for added energy support
- ✓Transparent pricing — exact cost shown upfront with no hidden fees
- ✓Competitive starting price from $133
Cons
- ✗Semaglutide only — no tirzepatide or liraglutide
- ✗No visible LegitScript or PCAB accreditation
- ✗State availability not disclosed
- ✗Broader platform (hormones, sexual wellness, hair health)
Zeuss
Pros
- ✓**No-subscription / one-time-purchase model is genuinely differentiated** — every other DTC GLP-1 competitor in the WLR directory uses monthly subscriptions with auto-renewal. Zeuss's 'pay only for the care you need' framing is unique.
- ✓Verbatim FDA compounded-medication disclaimer published — meets WLR transparency standard
- ✓Both 503A AND 503B compounding pathways explicitly mentioned — uncommon transparency
- ✓Bundled pricing structure includes everything (provider review + meds + cold-chain shipping + delivery) — no hidden fees framing
- ✓Full refund if physician cannot prescribe — reduces sign-up risk
- ✓$125/mo GLP-1 starting price is competitive with the broader DTC market
- ✓Cold-chain temperature-controlled shipping disclosed (uncommon detail)
- ✓Gender-segmented Body services accommodate buyers who prefer male-focused or female-focused clinical framing
Cons
- ✗Specific 503A pharmacy partner NOT named (only generic '503A and 503B state-licensed compounding pharmacies' framing)
- ✗LegitScript certification NOT mentioned on homepage or Body pages
- ✗Named medical director / physician leadership NOT disclosed
- ✗Full states-served list NOT disclosed (only 'US-licensed physicians' generic)
- ✗Corporate legal entity (LLC/Inc/PC) NOT disclosed in footer
- ✗Governing law / arbitration venue NOT disclosed
- ✗Subpath /body, /weight-loss return 404 — actual GLP-1 pages are at /services/body-for-him/ and /services/body-for-her/ (slightly awkward URL structure)
- ✗Site is JS-rendered SPA — content captured only via Chrome MCP, not WebFetch
- ✗Specific corporate physical address NOT disclosed in footer
- ✗$125 / $175 'starting at' framing suggests pricing may step up at higher dose tiers but tier structure not detailed on the public page
Our Verdict
Both Actin and Zeuss score equally well overall — the right choice depends on your priorities. Choose Actin if you want affordable compounded semaglutide with B12 enhancement, or Zeuss if Buyers who actively dislike subscription auto-renewals and want a one-time-purchase model for compounded GLP-1 or GIP/GLP-1 — the only provider in the WLR directory offering this billing model. Strong fit for cost-conscious patients who want bundled transparency (provider review + meds + cold-chain shipping + delivery for $125-$175) and the option to order only when needed. matters most to you.
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.